Britain’s largest energy supplier has urged households to reduce electricity usage during the upcoming solar eclipse, as the event could lead to a temporary drop in solar energy generation coinciding with a usual rise in demand. The warning comes as the UK prepares for the celestial phenomenon, which is expected to cause a significant reduction in solar power output. This could strain the national grid, especially during peak hours when energy consumption is typically highest. The company is advising residents to avoid using unnecessary appliances to help maintain grid stability.
The eclipse, which will be visible across parts of the UK, is expected to last several minutes at its peak, creating a unique challenge for energy providers. While the impact on the national grid is anticipated to be short-lived, the timing of the event aligns with a period of increased electricity demand, raising concerns about potential shortages. Energy experts are monitoring the situation closely to ensure that the grid remains balanced throughout the event.
In separate news, the UK has approved Eli Lilly’s weight-loss drug, Foundayo, for use in obesity treatment, marking a significant development in the field of diabetes and weight management. The medication, which is not yet available through the NHS, has received its first European approval in Britain, offering new options for patients seeking oral treatment.
